Intuitive Surgical (NASDAQ:ISRG) Trading Down 0.4% Following Insider Selling

Intuitive Surgical, Inc. (NASDAQ:ISRGGet Free Report) dropped 0.4% on Wednesday following insider selling activity. The stock traded as low as $569.49 and last traded at $571.69. Approximately 353,321 shares traded hands during trading, a decline of 82% from the average daily volume of 1,947,027 shares. The stock had previously closed at $574.14.

Specifically, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here.

Wall Street Analysts Forecast Growth

Several research firms have commented on ISRG. Piper Sandler reiterated an “overweight” rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research note on Friday, January 24th. CICC Research started coverage on Intuitive Surgical in a research report on Monday. They set a “neutral” rating and a $550.00 price target for the company. BTIG Research raised their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the company a “buy” rating in a report on Tuesday, November 26th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Royal Bank of Canada increased their target price on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday. One research analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $613.10.

Check Out Our Latest Analysis on ISRG

Intuitive Surgical Stock Performance

The firm has a market cap of $203.99 billion, a price-to-earnings ratio of 92.08, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The company has a 50 day moving average price of $548.70 and a 200 day moving average price of $507.04.

Institutional Inflows and Outflows

A number of large investors have recently bought and sold shares of ISRG. Mirador Capital Partners LP lifted its holdings in shares of Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock worth $1,732,000 after acquiring an additional 50 shares during the last quarter. M.E. Allison & CO. Inc. acquired a new stake in Intuitive Surgical in the 4th quarter valued at approximately $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical in the fourth quarter valued at approximately $82,517,000. Exome Asset Management LLC lifted its stake in Intuitive Surgical by 16.8% during the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after purchasing an additional 1,069 shares in the last quarter. Finally, Consolidated Planning Corp boosted its position in shares of Intuitive Surgical by 17.4% during the third quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after buying an additional 1,198 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.